The effect of DHEA complementary treatment on heroin addicts participating in a rehabilitation program: A preliminary study

European Neuropsychopharmacology

Volumn 18, Issue 6, 2008, Pages 406-413

  Maayan, Rachel ^a   Touati Werner, Dafna ^a   Shamir, David ^b   Yadid, Gal ^c   Friedman, Alexander ^c   Eisner, Dana ^a   Weizman, Abraham ^a,d   Herman, Issaschar ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b Jaffa Ctr Treatm Drug Dependent P   (Israel)

^c BAR ILAN UNIVERSITY   (Israel)

^d GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

Addiction; Cortisol; Dehydroepiandrosterone (DHEA); Detoxification; Heroin; Neurosteroids

Indexed keywords

BUPRENORPHINE; CHLORDIAZEPOXIDE; HYDROCORTISONE; IBUPROFEN; LOPERAMIDE; LORAZEPAM; METOCLOPRAMIDE; PAPAVERINE; PARACETAMOL; PLACEBO; PRASTERONE; TRAZODONE;

ABSTINENCE; ADD ON THERAPY; ADULT; ANXIETY; ARTICLE; BEDTIME DOSAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DETOXIFICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FOLLOW UP; HEROIN DEPENDENCE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REHABILITATION CARE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

ADJUVANTS, IMMUNOLOGIC; ANALYSIS OF VARIANCE; DEHYDROEPIANDROSTERONE; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; FUZZY LOGIC; HEROIN DEPENDENCE; HUMANS; HYDROCORTISONE; MALE; PSYCHIATRIC STATUS RATING SCALES; RESIDENCE CHARACTERISTICS; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 42749090801     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2007.12.003     Document Type: Article

References (48)

1. American Psychiatric Association. Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. Am. J. Psychiatry 152 Suppl (1995) 5
2. Backmund M., Meyer K., Eichenlaub D., and Schutz C.G. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substitute and codeine substituted patients. Drug Alcohol Depend. 64 (2001) 173-180
3. Baulieu E.E. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23 (1998) 963-987
4. Bezdek J. Pattern recognition with Fuzzy Objective Function Algorithms (1981), Kluwer Academic Norwell, New York
5. Buydens-Branchey, and Branchey. Association between low plasma levels of cholesterol and relapse in cocaine addicts. Psychosom. Med. 65 (2003) 86-91
6. Buydens-Branchey L., Branchey M., Hudson J., and Dorota Majewska M. Perturbations of plasma cortisol and DHEA-S following discontinuation of cocaine use in cocaine addicts. Psychoneuroendocrinology 27 (2002) 83-89
7. Caspi A., and Moffitt T.E. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat. Rev., Neurosci. 7 (2006) 583-590
8. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arseneault L., Williams B., Braithwaite A., Poulton R., and Craig I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene × environment interaction. Biol. Psychiatry 57 (2005) 1117-1127
9. Doron R., Fridman L., Gispan-Herman I., Maayan R., Weizman A., and Yadid G. DHEA, a Neurosteroid, Decreases Cocaine Self-Administration and Reinstatement of Cocaine-Seeking Behavior in Rats. Neuropsychopharmacology 31 (2006) 2231-2236
10. Dubrovsky B.O. Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 169-192
11. Goor D.A., Sheffy J., Schnall R.P., Arditti A., Caspi A., Bragdon E.E., and Sheps D.S. Peripheral arterial tonometry a diagnostic methods for detection of myocardial ischemia induced during mental stress tests: a pilot study,. Clin. Cardiol. 27 (2004) 137-141
12. Goeders N.E. Lapses and reinstatement of heroin seeking in rats: comment on Leri and Stewart. Exp. Clin. Psychopharmacol. 10 (2002) 356-358
13. Goeders N.E. The impact of stress on addiction. Eur. Neuropsychopharmacol. 13 (2003) 435-441
14. Haller D.L., and Miles D.R. Personality disturbances in drug-dependent women: relationship to childhood abuse. Am. J. Drug Alcohol Abuse 30 (2004) 269-286
15. Hamilton V. Theories of anxiety and hysteria-a rejoinder to Hans Eysenck. Br. J. Psychol. 50 (1959) 276-280
16. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
17. Hayashi T., and Su T.P. Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders. CNS Drugs 18 (2004) 269-284
18. Jaffe J.H., and Jaffe A.B. Opioid-related disorders. In: Kaplan H.I., Sadock B.A., and Sadock V.A. (Eds). Kaplan and Sadock's Comprehensive Textbook of Psychiatry (2000), Lippincott Williams and Wilkins, New York
19. Jaffe D.H., Eisenbach Z., Neumark Y.D., and Manor O. Individual, household and neighborhood socioeconomic status and mortality: a study of absolute and relative deprivation. Soc. Sci. Med. 60 (2005) 989-997
20. Jain A., and Dubes R.C. Algorithms for Clustering Data (1988), Prentice Hall
21. Koob G.F. A role for GABA mechanisms in the motivational effects of alcohol. Biochem. Pharmacol. 68 (2004) 1515-1525
22. Langeland W., Draijer N., and Van-den-Brink W. Psychiatric comorbidity in treatment-seeking alcoholics: the role of childhood trauma and perceived parental dysfunction. Alcohol Clin. Exp. Res. 28 (2004) 441-447
23. Leshner A.I. Drug abuse and addiction treatment research. The next generation. Arch. Gen. Psychiatry. 54 (1997) 691-694
24. Ling W., and Wesson D.R. Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Drug Alcohol Depend. 70 2 Suppl (2003) S49-S57
25. Maayan R., Lotan S., Doron R., Shabat-Simon M., Gispan-Herman I., Weizman A., and Yadid G. Dehydroepiandrosterone (DHEA) attenuats cocaine seeking behavior in the self-administration model in rats. Eur. Neuropsychopharmacology (ENP) 16 (2006) 329-339
26. Maayan R., Touati-Werner D., Ram E., Strous R., Ori D., and Weizman A. The protective effect of frontal-cortex, dehydroepiandrosterone in anxiety and depressive models in mice. Pharmacol. Biochem. Behav. 85 (2007) 415-421
27. A receptor: mechanism of action and physiological significance. Prog. Neurobiol. 38 (1992) 379-395
28. Majewska M.D. HPA axis and stimulant dependence: an enigmatic relationship. Psychoneuroendocrinology 27 (2002) 5-12
29. McLellan A.T., Grossman D.S., Blaine J.D., and Haverkos H.W. Acupuncture treatment for drug abuse: a technical review. J. Subst. Abuse Treat. 10 (1993) 569-576
30. Mulvaney F.D., Alterman A.I., Boardman C.R., and Kampman K. Cocaine abstinence symptomatology and treatment attrition. J. Subst. Abuse Treat. (1999) 16,129-16,135
31. Murray H.E., and Gillies G.E. Differential effects of neuroactive steroids on somatostatin and dopamine secretion from primary hypothalamic cell cultures. J. Neuroendocrinol. 9 (1997) 287-295
32. O'Brien C.P., Childress A.R., Ehrman R., and Robbins S.J. Conditioning factors in drug abuse: can they explain compulsion?. J. Psychopharmacol. 12 (1998) 15-22
33. O'Connor P.G., and Kosten T.R. Rapid and ultrarapid opioid detoxification techniques. JAMA 279 (1998) 229-234
34. Reynolds M., Mezy G., Chapman M., Wheeler M., Drummond C., and Baldacchino A. Co-morbid post-traumatic stress disorder in a substance misusing clinical population. Drug Alcohol Depend. 77 (2005) 251-258
35. Robel P., and Baulieu E.E. Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid. Ann. N. Y. Acad. Sci. 774 (1995) 82-110
36. Romieu P., Meunier J., Garcia D., Zozime N., Martin-Fardon R., Bowen W.D., and Maurice T. The sigma1 (sigma1) receptor activation is a key step for the reactivation of cocaine conditioned place preference by drug priming. Psychopharmacology (Berl) 175 (2004) 154-162
37. Rosen C.S., Quimette P.C., Sheikh J.I., Gregg J.A., and Moos R.H. Physical and sexual abuse history and addiction treatment outcome. J. Stud. Alcohol 63 (2002) 683-687
38. Rutter J.L. Symbiotic relationship of pharmacogenetic and drugs of abuse. AAPS J. 8 (2006) E174-E284
39. Shoptaw S., Majewska M.D., Wilkins J., Twitchell G., Yang X., and Ling W. Participants receiving dehydroepiandrosterone during treatment for cocaine dependence show high rates of cocaine use in a placebo-controlled pilot study. Exp. Clin. Psychopharmacol. 12 (2004) 126-135
40. Schneider H.P. Androgens and antiandrogens. Ann. N. Y. Acad. Med. 997 (2003) 292-306
41. Strous R.D. Dehydroepiandrosterone (DHEA) augmentation in the management of schizophrenia symptomatology. Essent. Psychopharmacol. 6 (2005) 141-147
42. Strous R.D., Maayan R., Kotler M., and Weizman A. Hormonal profile effects following dehydroepiandrosterone (DHEA) administration to schizophrenic patients. Clin. Neuropharmacol. 28 (2005) 265-269
43. Su T.P., and Hayashi T. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr. Med. Chem. 10 (2003) 2073-2080
44. Wilkins J., Van Gorp W., Hinken C., Welch B., Wheatley S., Plotkin D., Moore L., Setoda D., Ashofteh A., and Majewska M.D. Relapse to cocaine use may be predicted in early abstinence by low plasma dehydroepiandrosterone. NIDA res. Monogr. 174 (1997) 183
45. Wilkins J.N., Majewska M.D., Van Grop W., Li S.H., Hinken C., Pltkin D., and Setoda D. DHEAS and POMS measures identify cocaine dependence treatment outcome. Psychoneuroendocrinology 20 (2005) 18-28
46. Wolkowitz O.M., Reus V.I., Roberts E., Manfredi F., Chan T., Raum W.J., Ormiston S., Johnson R., Canick J., Brizendine L., and Weingartner H. Dehydroepiandrosterone (DHEA) treatment of depression. Biol. Psychiatry 41 (1997) 311-318
47. Wu F.S., Gibbs T.T., and Farb D.H. Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-d-aspartate receptor. Mol. Pharmacol. 40 (1991) 333-336
48. Yang M. A survey of fuzzy clustering. Math. Comput. Model. 18 (1993) 1-16